- Home
- Search Results
Search Results
Filter :
FILTER BY keyword:
- COVID-19 [5]
- SARS-CoV-2 [2]
- ABO blood groups [1]
- ACE2 expression [1]
- Artificial Intelligence (AI) [1]
- Community-Acquired Pneumonia (CAP) [1]
- Dapsone [1]
- Drug-Induced Methemoglobinemia [1]
- Eastern Mediterranean Region [1]
- Ethnicity [1]
- G6PD [1]
- ICU mortality [1]
- ITP [1]
- Immune thrombocytopenic purpura [1]
- Intensive Care Unit (ICU) [1]
- Machine Learning (ML) [1]
- Methemoglobinemia [1]
- Open Access [1]
- Open Educational Resources [1]
- Qatar [1]
- Radiology nursing [1]
- Rh blood groups [1]
- Rituximab [1]
- Sepsis [1]
- Sepsis-Associated Delirium (SAD) [1]
- Sepsis-Associated Encephalopathy (SAE) [1]
- aI-assisted diagnostic imaging [1]
- absolute neutrophil count [1]
- acute pancreatitis [1]
- acute respiratory distress syndrome [1]
- [+] More [-] Less
FILTER BY author:
- Abdulqadir J. Nashwan [12]
- Mohamad Y. Khatib [5]
- Mohammad Al Wraidat [3]
- Moustafa S. Elshafei [3]
- Nevin Kannappilly [3]
- Dore C. Ananthegowda [2]
- Fateen Ata [2]
- Karimulla S. Shaik [2]
- Mohamed A. Yassin [2]
- Mohamed Z. Peediyakkal [2]
- Aans Baiou [1]
- Abeer Sabry Safan [1]
- Adel Issam Al Bozom [1]
- Ahmed A. Karawia [1]
- Ahmed Hatim. Mohamed [1]
- Ahmed S. Mohamed [1]
- Ahmed S. Mohmed [1]
- Ahmed T. Kbaiah [1]
- Altaib Baloul [1]
- Amer A. Tot [1]
- Amer Ali Farooqi [1]
- Anas Mohamed Babiker [1]
- Anood Al-Assaf [1]
- Arunkumar Venkatesan [1]
- Ashraf T. Soliman [1]
- Asra Aroos [1]
- Ayisha Ameen [1]
- Bassem N. Alhariri [1]
- Doaa H. Ahmed [1]
- Ebrahim M.A. Ebrahim [1]
- [+] More [-] Less
FILTER BY language:
FILTER BY content type:
FILTER BY publication:
FILTER BY affiliation:
- Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar [2]
- Clinical Imaging Department, Hamad Medical Corporation, Doha, Qatar [1]
- Clinical Pharmacy Department, Communicable Diseases Center, Doha, Qatar [1]
- Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar [1]
- Critical Care Department, Hamad Medical Corporation (HMC), Doha, Qatar E-mail: [email protected] [1]
- Critical Care Department, Hamad Medical Corporation (HMC), Doha, Qatar Email: [email protected] ORCID iD: https://orcid.org/0000-0003-4845-4119 [1]
- Critical Care Department, Hamad Medical Corporation, Doha, Qatar [1]
- Critical Care Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar [1]
- Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar*Correspondence: Salah almughalles [email protected] [1]
- Department of Critical Care Medicine, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar. E-mail: [email protected] [1]
- Department of Gastroenterology and Hepatology Hamad Medical Corporation, Doha Qatar Email & ORCID ID: [email protected] & https://orcid.org/0000-0001-7121-8574 [1]
- Department of Hematology and Oncology National Center for Cancer care and research (NCCCR), Doha, Qatar [1]
- Department of Infectious Diseases, Hazm Mebaireek General Hospital, Qatar [1]
- Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar E-mail: [email protected];[email protected] [1]
- Department of Internal Medicine, Hamad Medical Corporation (HMC), Doha, Qatar [1]
- Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar [1]
- Department of Medical Education, Hamad General Hospital, Qatar [1]
- Department of Medical ICU/Medicine, Hamad General Hospital, Qatar Email: [email protected] [1]
- Department of Medical Oncology/Hematology, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar [1]
- Department of Medicine, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar [1]
- Department of Nursing for Education & Practice Development, Hamad Medical Corporation, Doha, Qatar [1]
- Department of Nursing, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar E-mail: [email protected] [1]
- Department of Paediatrics. Hamad Medical Corporation (HMC), Doha, Qatar [1]
- Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. [1]
- Faculty of Nursing, University of Calgary in Qatar (UCQ), Doha, Qatar. [1]
- Hamad Medical Corporation, Doha, Qatar [1]
- Hamad Medical Corporation, Doha, Qatar Email: [email protected] [1]
- Hamad Medical Corporation, Doha, Qatar. *Email: [email protected] [1]
- Hamad Medical Corporation, Doha, Qatar. Email: [email protected] [1]
- Harvard TH Chan School of Public Health, Boston, USA [1]
- [+] More [-] Less
FILTER BY article type:
FILTER BY access type:
Unlocking Scientific Potential: The Rise of Open Access in the Eastern Mediterranean Region
Open Access (OA) initiatives are pivotal in democratizing knowledge fostering research and encouraging global collaboration. This paper highlights the progress of OA initiatives in Eastern Mediterranean Region (EMR) countries as designated by the World Health Organization. EMR countries have embraced OA to bridge the gap between high-income and lower-middle-income countries (LMICs) especially in healthcare and medicine. This is exemplified by initiatives like the Egyptian Knowledge Bank (EKB) which provides Egyptians free access to extensive scientific publications e-books and multimedia resources from international publishers. EKB aims to democratize knowledge and cultivate learning research and innovation in Egypt. Qatar National Library (QNL) is another prime example investing considerably in OA by providing access to international resources and databases. Through the Open Access Author Fund (OAAF) QNL covers Article Processing Charges (APC) for Qatar-based researchers publishing in OA journals and supports the development of a knowledge-based society in Qatar. In the United Arab Emirates the national policy on Open Educational Resources (OER) facilitates access to knowledge by encouraging the use and sharing of OER in education and research. However despite these strides challenges still need to be addressed including limited funding lack of infrastructure and low OA awareness among researchers and institutions. Moreover a unified regional strategy is necessary to ensure effective OA implementation.
Community-Acquired Pneumonia with rapidly progressing pleural effusion within 24 hours: A case report
Patients with Community-Acquired Pneumonia (CAP) complicated with pleural effusion mostly present with shortness of breath and pleuritic chest pain and usually pleural fluid (PE) progresses gradually. In this report a case of CAP patient complicated with PE presented with left shoulder pain is discussed. The PE was found to have rapidly accumulated as a massive effusion within 24 hours of presentation. Thoracocentesis was performed and revealed an exudative picture. Patients with CAP can present with atypical symptoms on admission but may develop massive parapneumonic pleural effusion within a short time that would need definite management via urgent chest tube placement.
Beyond the Image: Artificial Intelligence’s Role in Refining and Transforming Radiology Nursing
Artificial Intelligence (AI) is set to significantly transform the role of radiology nurses by enhancing their responsibilities and patient care. AI will streamline workflow and decision-making allowing nurses to focus more on patient care by providing quick access to complex diagnostic information. This shift reduces the focus on administrative tasks leading to more efficient patient responses. AI tools will also improve the precision of procedures like image-guided biopsies reducing discomfort and improving outcomes. Nurses will need to develop new technical skills to operate these AI-assisted tools effectively. This letter explores the evolving role of radiology nursing role in the era of AI.
Dear Editor
The field of radiology is experiencing rapid growth due to advancements in technology and imaging. Minimally invasive percutaneous approaches assisted by radiologic techniques are enhancing outcomes while simultaneously decreasing patient discomfort recovery periods and hospitalization durations [1]. Image-guided biopsies have become the preferred alternative to costly surgical interventions like exploratory laparotomies and procedures such as radiofrequency ablations offer a viable treatment choice for individuals with liver cancer who are not eligible for surgery [2].
Radiology or clinical imaging nursing allows nurses to apply a range of skills in providing care to both adult and pediatric patients. This letter explores the evolving role of radiology nursing role in the era of artificial intelligence (AI).
Radiology nurses require extensive knowledge and independence to meet diverse patient needs. Their duties include managing intravenous lines medication administration vital sign monitoring and providing personal care. They communicate patient needs to other medical staff administer sedation and monitor patients with advanced equipment. Additionally they educate patients families and healthcare staff contribute to quality improvement and develop patient care policies. Their role is crucial in both emergency and routine care settings [2]. Incorporating skills from various nursing specialties radiology nurses strive to deliver high-quality nursing care to a diverse and transient patient population of all ages. They serve as advocates for patient care and act as educators for other radiology staff members on pertinent patient care issues [2].
Many radiology nurses transition from backgrounds in intensive care units (ICU) emergency departments (ED) or post-anesthesia care units (PACU). Despite being seasoned experts in their previous specialties adapting to the radiology environment poses a significant learning curve due to factors such as the variety of imaging modalities the multitude of procedures the mix of skills within the department the level of autonomy and the absence of routine. However once acclimated nurses often find the specialty rewarding and are less inclined to leave [2].
The Clinical Imaging setting operates at a high speed with Clinical Imaging nursing experiencing swift expansion. Clinical Imaging nurses play a vital role in delivering outstanding patient care. This distinct field provides autonomy and chances to cater to diverse patient needs through the utilization of advancing technologies [3].
The AI is set to significantly transform the role of nurses and radiology nurses in particular by enhancing their responsibilities and patient care [4]. AI will streamline workflow and decision-making allowing nurses to focus more on patient care by providing quick access to complex diagnostic information [5]. This shift reduces the focus on administrative tasks leading to more efficient patient responses. AI tools will also improve the precision of procedures like image-guided biopsies reducing discomfort and improving outcomes. Nurses will need to develop new technical skills to operate these AI-assisted tools effectively.
Moreover the educational responsibilities of radiology nurses will increase necessitating continuous learning and teaching about evolving AI technologies. AI’s assistance in patient monitoring will enable nurses to provide more personalized care concentrating on crucial aspects like patient comfort and emergency care. AI will also aid in quality improvement data analytics and development of effective patient care strategies. Additionally AI supports the creation of personalized care plans by analyzing extensive patient data. Radiology nurses must keep up to date with AI advancements for their professional development ensuring their skills remain relevant.
Liver ultrasound evaluation of acutely increased liver function tests of COVID-19 hospitalized patients
Background: The incidence of hepatic abnormalities has been notably higher following the coronavirus disease 2019 (COVID-19) infection attributed to the virus’s entry into cells via angiotensin-converting enzyme 2 (ACE2) surface expression. The gastrointestinal tract’s significant ACE2 expression alongside a lesser degree in the biliary epithelium has been implicated in gastrointestinal symptoms and liver injury.
Purpose: The aim of this study was to determine whether specific ultrasonographic findings in the liver correlate with acute increases in liver function tests (LFTs) among hospitalized patients.
Methods: A retrospective analysis was conducted on hospitalized COVID-19 patients at Hazem Mebaireek General Hospital in Qatar from March 1 2020 to June 30 2020. The study focused on patients who experienced acute increases in LFTs excluding those with chronic liver disease. Ultrasound imaging and patient records were reviewed to gather data.
Results: Out of 223 ultrasound studies of COVID-19 patients 158 met the inclusion criteria. The majority were male with a mean age of 47.76 ± 13.76 years. Ultrasound results showed 43.7% normal liver parenchyma while 56.3% exhibited nonspecific abnormalities such as diffuse liver hyperechogenicity (39.2%) enlargement with diffuse hyperechogenicity (12.7%) and other findings (4.4%). The biliary tree was predominantly normal (96.2%) with 3.8% showing abnormalities including intrahepatic (2.5%) and extrahepatic (1.3%) dilatation. Gallbladder evaluations were normal in 60.1% of cases with 39.9% showing abnormalities like stones (6.3%) stones with sludge (13.3%) polyps (6.3%) wall thickening (1.9%) and other conditions (12%). A significant correlation was found between abnormal liver parenchyma findings and elevated levels of bilirubin (total and direct) and alkaline phosphatase with p-values < 0.05. Only aspartate aminotransferase levels showed a significant correlation with biliary tree abnormalities.
Conclusion: The most common ultrasonographic finding associated with acute increases in LFTs among hospitalized COVID-19 patients was diffuse liver hyperechogenicity with or without enlargement. These findings suggest a nonspecific yet significant association with liver function anomalies in the context of COVID-19.
Artificial Intelligence Applications in the Intensive Care Unit for Sepsis-Associated Encephalopathy and Delirium: A Narrative Review
Background: Sepsis a life-threatening condition triggered by an altered immune response to infection poses significant challenges in clinical management.
Aim: This review discusses the role of Artificial Intelligence (AI) in predicting Sepsis-Associated Encephalopathy (SAE) and Sepsis-Associated Delirium (SAD).
Methods: A thorough search encompassing PubMed CINAHL Medline and Google Scholar yielded studies published from 2010 to 2023.
Results: The narrative review emphasizes AI's potential in the early identification and prognosis of SAE and SAD specifically through machine learning and deep learning methods such as XGBoost.
Conclusion: This review underscores the importance of early detection in sepsis and emphasizes how AI can improve prediction accuracy offering promise in transforming the management of these complex neurological complications within the intensive care unit (ICU).
Tension Pneumomediastinum: A life-threatening condition in patients with COVID-19
Tension pneumomediastinum (TPM) is a rare but potentially fatal clinical entity. TPM leads to the leakage of air into the mediastinal cavity and increased pressure in thoracic vessels respiratory tract and the heart. Herein this report presents a series of five cases of coronavirus disease-2019 (COVID-19) that caused acute respiratory distress syndrome (ARDS) and TPM. All patients were male who had severe ARDS with a secondary lung infection that required invasive ventilation and had moderate positive-end expiratory pressure. All patients required vasopressors to maintain hemodynamics and two patients needed decompression with chest drains. One patient received extracorporeal membrane oxygenation therapy. Three patients had cardiac arrest and two patients died; thus the mortality rate was 40%. Patients with COVID-19 pneumonia with ARDS required invasive ventilation and prone positioning. Secondary lung infection can cause TPM and TPM may cause cardiac arrest. Management should be prompt recognition and decompression with the insertion of drains and conservative treatment is required in stable cases. Protocols for the management of pneumomediastinum and TPM may enable early detection earlier management and prevention of TPM.
Epidemiology, clinical features, and management of hypertriglyceridemia-induced pancreatitis: A case series
Background: Hypertriglyceridemia-induced pancreatitis accounts for up to 15 % of all acute pancreatitis admitted to hospitals. It is important to diagnose the etiology to provide adequate and timely management of the case and reduce complications. Epidemiological and clinical data on hypertriglyceridemia-induced pancreatitis in the Intensive Care Unit (ICU) are scarce especially in Middle Eastern countries. We are reporting a case series of 18 patients admitted managed in the ICU over a period of 10 months. Methods: All patients above 18 years of age were diagnosed with hypertriglyceridemia-induced pancreatitis admitted to the ICU and High Dependency Unit (HDU) were included. Our objectives were to characterize the clinical and epidemiological features of hypertriglyceridemia-induced pancreatitis (HTG-AP) and calculate the number of insulin infusion days required to manage HIP. Results: Patients were mostly middle-aged males from different ethnicity. Most of the patients presented with abdominal pain elevated pancreatic enzymes and triglyceride. The mean triglyceride level on admission was 15.68 mmol/L. Most clinical findings were resolved when the triglyceride level dropped to below 5.6 mmol/L within 3.5 days. All patients presented with mild forms of pancreatitis without major complications. Fifty percent of our patients showed radiological features of acute pancreatitis but no one developed local complications. Conclusion: Our case series showed that hypertriglyceridemia is a common cause of acute pancreatitis in Qatar. Upon admission the mean triglyceride level was 15.68 mmol/L and the cause of the hypertriglyceridemia was unclear but could be related to ethnicity. Patients were primarily managed with insulin therapy and supportive care. None of the patients developed any local complications such as necrotizing pancreatitis or abscess formation. Around 16% of the patients had systemic complications which were managed successfully.
Methemoglobinemia induced by Dapsone: A case report
Many drugs can cause methemoglobinemia and dapsone is one of the most familiar. Dapsone is used to treat skin disorders like leprosy and infections like Pneumocystis jiroveci pneumonia. It is also used off-label in conditions like dermatitis herpetiformis and relapsing polychondritis. In this case report a 26-year-old male presented to the emergency department with fever and generalized weakness complaints. He was on treatment for lepromatous leprosy with dapsone clofazimine and rifampicin. His room air oxygen saturation was 80 % so he was started on high-flow oxygen therapy and vitamin C. His blood gas and methemoglobin levels were frequently monitored till the methemoglobin level was normal. By the third day he maintained his saturation above 95% on room air. The results in this work emphasize the importance of evaluating hypoxia for uncommon causes like methemoglobinemia as misdiagnosis can lead to fatal complications.
Efficacy and safety of rituximab as second-line therapy in immune thrombocytopenic purpura based on ethnicity: A descriptive study among the Arabic population
Background: Rituximab is used as second-line therapy in patients with immune thrombocytopenic purpura (ITP) who do not respond to first-line management. The response rate for Rituximab is variable in different populations ranging from 30% to 90%. The adverse effects of rituximab in patients with ITP range from infusion site reactions to the reactivation of hepatitis B virus and progressive multifocal leukoencephalopathy and interpopulation variation.
Methods: We conducted a single-center retrospective study in Qatar's National Center for Cancer Care & Research. The study included patients with chronic refractory ITP who received rituximab as second-line therapy. Descriptive and summary statistics were used to describe the sociodemographic parameters of the study cohort.
Results: Of the 41 patients with chronic ITP 26 were Arabs 12 were Asians and 3 were of other ethnicities. Rituximab was associated with an overall response rate of 80.4%. Arabic patients had the highest clinical response (84.6%) among the ethnicities with the lowest adverse effects (11.5%). Asians had a response rate of 66.6% and adverse effects were seen in 16.7% of the patients.
Conclusions: In chronic refractory ITP rituximab appears to have a better clinical response in the Arabic population with minimal toxicity than in other ethnicities.
Association between blood groups and clinical outcomes in critically ill COVID-19 patients: A retrospective study
Introduction: A small proportion of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) become critically ill. Individuals’ blood group may influence their susceptibility to infection. However the relationship between blood groups and clinical outcomes in severe Coronavirus disease 2019 (COVID-19) is not well established. Therefore we conducted a study to investigate the association between blood groups and clinical outcomes in critically ill COVID-19 patients.
Methods: We retrospectively analyzed electronic health records of COVID-19 patients admitted to intensive care units (ICUs) at Hazm Mebaireek General Hospital Qatar from March 7th 2020 to July 15th 2020. The study population was divided based on their blood groups into types A B AB O Rhesus (Rh)-positive and Rh-negative. The primary outcome studied in each blood group was all-cause ICU mortality. Secondary outcomes evaluated were the requirement and duration of mechanical ventilation ICU days hospitalization days and C-reactive protein (CRP) value on admission.
Results: Eight hundred forty-eight patients were admitted to ICUs with severe COVID-19 during the study period. All-cause ICU mortality in the study population was 19.8% (168/848) and that in individuals with blood groups A B AB O Rh-positive and Rh-negative was 22.6% (52/230) 18.1% (44/243) 22% (18/82) 18.4% (54/293) 20.4% (165/810) and 7.9% (3/38). Although the highest mortality was noted in blood group A followed by AB these observations failed to achieve statistical significance. Rh-negative blood type had lower odds of death compared to the Rh-positive one (odds ratio = 0.27; 95% confidence interval 0.08–0.99 P = 0.049). None of the blood groups showed an association with the need for mechanical ventilation duration of mechanical ventilation duration of ICU and hospital stay and CRP value on admission.
Conclusion: This study revealed no association between ABO blood groups and unfavorable clinical outcomes in critically ill COVID-19 patients. The Rh-negative blood type was associated with slightly lower odds of death compared to the Rh-positive one.
COVID-19-associated neurological sequelae: A case series on cerebral microbleeds and encephalopathy
Background: Critical illness-associated cerebral microbleeds and leukoencephalopathy connected to coronavirus disease 2019 (COVID-19) infection are emerging areas of concern in current medical literature.
Methods: We reviewed cases of patients with COVID-19-associated neurological manifestations to study the prevalence and outcome of such conditions.
Case Series Findings: Our review yielded seven distinct patients. Six exhibited cerebral microbleeds primarily localized in the juxtacortical white matter and the corpus callosum. In contrast one individual presented with leukoencephalopathy. Tragically of these patients five succumbed to their ailments. One was discharged with mild cognitive impairments while another underwent a tracheostomy and was subsequently moved to a long-term care establishment.
Conclusion: Our findings underscore the significance of neuro-radiological observations in those grappling with severe manifestations of COVID-19 drawing attention to the possible neurological repercussions of the virus.
Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study
Introduction: Patients with multiple comorbidities who have coronavirus disease 2019 (COVID-19) have high morbidity and mortality. Glucose-6-phosphate dehydrogenase (G6PD) deficiency has been shown to have an enhanced effect on coronavirus in an earlier study.
Methods: We conducted this comparative observational study to evaluate the effects of COVID-19 disease on G6PD deficiency based on the hematologic parameters COVID-19-related hospitalizations and mortality in the state of Qatar between January 2020 and May 2020 at four designated COVID-19 facilities. We identified 41 patients with G6PD deficiency who had documented COVID-19 infection. We compared the results with 241 patients with COVID-19 infection who tested negative for G6PD deficiency.: Results: Comparing the COVID-19 positive G6PD deficient with COVID-19 positive G6PD normal activity showed that G6PD normal group had higher white blood cell count (WBC) absolute neutrophil count (ANC) lymphocytes eosinophils and monocytes counts versus the G6PD deficient group (p < 0.001).
Conclusions: When compared with COVID-19 patients with normal G6PD patients with COVID-19 infection and G6PD deficiency had lower total WBC ANC lymphocyte monocyte and eosinophil counts. However no evidence of increased hemolysis thrombosis morbidity or mortality was observed in COVID-19 patients with G6PD deficiency.